Identification and pathogenicity analysis of a novel non-tuberculous mycobacterium clinical isolate with nine-antibiotic resistance  by Zhang, Z.-Y. et al.
Identiﬁcation and pathogenicity analysis of a novel non-tuberculous
mycobacterium clinical isolate with nine-antibiotic resistance
Z.-Y. Zhang1,*, Z.-Q. Sun2,*, Z.-L. Wang3, H.-R. Hu1, Z.-L. Wen1, Y.-Z. Song2, J.-W. Zhao1, H.-H. Wang2, X.-K. Guo1 and
S.-L. Zhang1
1) Department of Medical Microbiology and Parasitology, Institutes of Medical Sciences, Shanghai Jiao-Tong University School of Medicine, Shanghai, 2) State
Key Laboratory of Genetic Engineering/Shanghai Public Health Clinical Centre, Fudan University, Shanghai and 3) Research Centre for Tuberculosis, Henan
Chest Hospital, Zhengzhou, Henan, China
Abstract
With mycobacteriosis increasing, the study of non-tuberculous mycobacteria is imperative for clinical therapy and management. Non-
tuberculous mycobacteria are naturally resistant to most anti-tuberculosis drugs. Accordingly, it is important to decipher the biology of
the novel non-tuberculous mycobacteria through complete genomic analysis of novel pathogenic mycobacteria. We describe Mycobacte-
rium sinense JDM601, a novel, slow-growing mycobacterium of the Mycobacterium terrae complex resistant to nine antibiotics, by clinical
presentation, cultural and biochemical characteristics, minimal inhibitory concentrations, and genome-sequencing analysis. JDM601 is
closest to Mycobacterium nonchromogenicum according to mycolic acid composition, but closest to Mycobacterium algericum sp. nov
according to 16S rDNA. JDM601 is resistant to isoniazid, streptomycin, rifampin, euteropas, protionamide, capromycin, ciproﬂoxacin,
amikacin and levoﬂoxacin but not ethambutol. The clinical information, mycolic acid composition, and virulence genes indicate that
JDM601 is an opportunistic pathogen.
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Introduction
Infections caused by non-tuberculous mycobacteria (NTM)
have risen steadily over the last several decades in China and
around the world [1,2]. The NTM are naturally resistant to
most anti-tuberculosis drugs. Traditional therapy to cure
complicated infections caused by novel NTM, especially
tuberculosis-like disease, has been limited. A deﬁnite identiﬁ-
cation of a given clinical isolate may lead to a better estima-
tion of the pathogenicity and epidemiology of this organism.
Mycobacterium terrae complex (MTEC) includes M. terrae,
M. triviale, M. nonchromogenicum and M. hiberniae. Despite the
common opinion that MTEC isolates are non-pathogenic,
these organisms are occasionally identiﬁed in the clinical dis-
ease setting [3,4]. Mycobacterium senuense and M. paraterrae
are two novel MTEC species recently isolated from pulmo-
nary infection patients [5,6]. Because of the presumed non-
pathogenic nature of MTEC, there has been little effort to
distinguish the species of this complex in the clinical setting
in the past century. However, MTEC infection can cause
debilitating disease that is relatively resistant to antibiotic
therapy. We identiﬁed a novel pathogenic mycobacterium
resistant to nine antibiotics that was isolated from a patient
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with tuberculosis-like disease, and determined the whole
genome sequence for further analysis (accession number
CP002329) [7].
Materials and Methods
Patient
A 34-year-old woman presented to her primary physician
with chest pain in March 2006. Left-lung inﬁltrates were
found using chest X-ray. The detection of acid-fast bacilli ini-
tially led to treatment with anti-tuberculosis drugs. As a con-
sequence of the progression of the pulmonary inﬁltrates, she
was transferred to another hospital 6 months later. There,
computerized tomography of her chest suggested left pneu-
monitis. The acid-fast bacillus staining gave a strongly positive
result, graded as 4-plus smear, so she was primarily diag-
nosed with pulmonary tuberculosis and was treated empiri-
cally with isoniazid, rifampin, pyrazinamide and ethambutol
for 3 months. On the basis of mycobacterial identiﬁcation
and in vitro drug-susceptibility test results, second-line antibi-
otics were added, and speciﬁc antibiotics were administered.
Finally, the infection cleared after prolonged multidrug antibi-
otic therapy (ending in October 2008).
Strain identiﬁcation
Strain JDM601 was isolated from the sputa of the patient
with a symptomatic pulmonary infection. Successive isola-
tions of the same strain as that isolated from the sputa of
this patient had been observed three times without isolation
of other mycobacteria.
Detailed conventional biochemical testing procedures and
quality control measures were performed [8]. The pheno-
typic characteristics of strain JDM601 and reference strain
M. tuberculosis H37Rv were analysed and compared. The
mycolic acids of JDM601 were analysed using the MIDI Sher-
lock Microbial Identiﬁcation System. We performed taxon-
omy analysis for JDM601 based on the 16S rDNA and hsp65
sequences of 19 mycobacteria from different species. Refer-
ence sequences were obtained from GenBank.
Antibiotic resistance and MIC measurement
The use of in vitro susceptibility testing for JDM601 was con-
sistent with the Clinical and Laboratory Standards Institute
(CLSI) recommendations. Minimal inhibitory concentrations
(MICs) for ten drugs, including isoniazid, streptomycin, rifam-
pin, euteropas, protionamide, capromycin, ciproﬂoxacin, ami-
kacin, levoﬂoxacin and ethambutol, were determined [9].
Results
Species identiﬁcation
JDM601 was a slow-growing mycobacterium (SGM); 3 weeks
or more were required to form mature colonies on Lowen-
stein–Jensen medium. The biochemical characteristics of
JDM601 are shown in Table 1. JDM601 was distinguished
from the other species.
TABLE 1. Biochemical characteristics of Mycobacterium sinense JDM601 compared with other mycobacteria
Characteristic 1 2 3 4 5 6 7 8 9
Growth at:
28C + ) + + ) + ) + +
37C + + + + + + + + +
Growth speed S S S R(S) S S(R) S S R
Morphology R’ R’ S’(R’) S’ S’(R’) S’(R’) R’(S’) S’ R’
Pigmentation N N N N N P N N N
Nitrate reductase ) + + + V ) ) ) +
Arylsulphatase (9 days) ) ) + ) + + V ) )
Tellurite reductase + + + + + U + + U
Tween-80 hydrolysis
<5 days ) ) + V + + ) ) +
>10 days + + + + + + V ) +
Urease + + ) ) ) + + ) +
Growth on/in:
TCH + + + + + + ) + +
Para-nitrobenzoic acid ) ) + ) V V ) + +
5% NaCl + ) ) ) ) ) ) ) +
MacConkey agar ) ) U ) ) U U U U
Picric acid ) ) U ) ) U U U +
Catalase ) ) + U + V ) V +
Nicotinic acid ) + ) U U V ) ) )
Phosphatase ) ) + U + + ) ) )
Iron absorption (7 days) + ) + U U ) ) ) +
1, M. sinense JDM601; 2, M. tuberculosis H37Rv; 3, M. terrae; 4, M. senuense [5]; 5, M. nonchromogenicum; 6, M. marinum; 7, M. bovis; 8, M. avium; 9, M. smegmatis;1  3 and
5  9 [23]. R, rapid; S, slow; V, partly positive; +, positive; ), negative; U, unknown. R’, rough; S’, smooth; N, non-photochromogenic; P, photochromogenic.
TCH, thiophene-2-carboxylic acid hydrazide.
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JDM601 belonged to MTEC, and the phylogenetic trees
were constructed separately based on both the 16S rDNA
and hsp65 sequences (Fig. 1). To maximize the speciﬁcity,
the full-length 16S rDNA sequences were cut into 1350 base
pairs (bp), which were the common segments of 20 strains.
According to 16S rDNA sequence analysis, the closest
known species to JDM601 was M. terrae, and the second
closest was M. senuense. The full-length 16S rDNA
sequences (1350 bp) of JDM601 and M. terrae had 99% iden-
tity and eight single nucleotide polymorphisms, ﬁve of which
were located between bases 990 and 1150. However,
M. senuense is closer to JDM601 than M. terrae on the hsp65
tree. Most SGM had only one rRNA operon, as compared
with two operons in rapid-growing mycobacteria (RGM).
However, JDM601 belonged to SGM and had two of the
same rRNA operons according to the complete genome
sequence. Two sets of different operons have been reported
in M. terrae [10].
FIG. 1. Phylogenetic relationships of JDM601 to other Mycobacterium species. Two trees were constructed using the neighbour-joining method
based on 16S rRNA (a) and hsp65 (b) gene sequences. Percentages indicated at the nodes represent bootstrap levels supported by 1000 resam-
pled datasets. Rhodococcus equi was used as an outgroup for both trees. Bar, 1% (a) and 0.5% (b) sequence difference.
FIG. 2. Comparison chart of JDM601
with Mycobacterium nonchromogenicum.
All fatty acids found in sample and
library entries were vertically listed in
elution order on the left side of the
chart. A scale of percentages was
printed across the bottom of the chart.
For each acid, the bar represented a
± 2 standard deviation window around
the entry mean, which is identiﬁed by a
bold vertical line. The oval on the bar
indicates the amount of that acid in
JDM601. SF, Summed Feature.
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The JDM601 mycolic acid composition was matched with
those of known organisms stored in the Standard Libraries.
Only one similar organism, M. nonchromogenicum, was found,
and it had a low similarity index (SI = 0.416) (Fig. 2). Most of
their fatty acid types coincided, and the variation lay within
the error margin. However, the amount of C18: 2w6,9c fatty
acid was much higher in JDM601, and C20:0 fatty acid was
not detectable in JDM601.
According to the biochemical and molecular taxonomy
analysis, JDM601 should be a new species belonging to
MTEC. We named the species Mycobacterium sinense. The
species name ‘sinense’ means ‘belonging to China’, indicating
the source of the type strain.
Antibiotic resistance analysis
As was observed using the agar plate proportion method,
the JDM601 strain was resistant to nine drugs but not
ethambutol (Table 2). JDM601 was extremely resistant to
isoniazid and euteropas, with MICs larger than the testing
maximum; it was highly resistant to streptomycin, cipro-
ﬂoxacin, levoﬂoxacin, capromycin and protionamide; and it
was moderately resistant to rifampin and amikacin.
Discussion
Taxonomy
Phenotypically, the biochemical proﬁle of JDM601 did not
coincide with any mycobacterial strain. JDM601 had many
common characteristics with M. terrae, M. senuense and
M. nonchromogenicum, but had nitrate reductase, urease,
phosphatase and catalase activities opposite to these species.
Additionally, JDM601 shared a common arylsulfatase activity
and para-nitrobenzoic acid resistance phenotype with
M. senuense but not with the other two species. Interest-
ingly, JDM601 was resistant to 5% NaCl, which was typical
for RGM. The resistance to high concentrations of salt and
adaptability to low temperature indicated the ability of
JDM601 to survive in the environment.
Though the mycolic acid composition of JDM601 was simi-
lar to that of M. nonchromogenicum, the identiﬁcation using
the similarity index was difﬁcult, especially with the absence of
C20:0 fatty acid. Furthermore, according to the molecular
sequencing analysis of 16S rDNA or hsp65, JDM601 was more
closely related to M. terrae than to M. nonchromogenicum.
JDM601 can be separated from M. terrae and M. senuense
by both 16S rDNA and hsp65 sequencing, with much larger
difference within MTEC. As reported by Dai et al. [11],
according to hsp65 sequences, M. hiberniae and M. nonchrom-
ogenicum belong in one clade with M. chelonae, and M. ab-
scessus belong to RGM but not MTEC. Mycobacterium triviale,
M. nonchromogenicum and M. hiberniae have frequently been
placed in the RGM group or between RGM and SGM [12].
Mycobacterium algericum sp. nov is the latest novel RGM spe-
cies identiﬁed as belonging to MTEC [13]. The conserved
genes of JDM601 were much more similar to M. algericum
than to M. terrae, but their biochemical characteristics and
mycolic acid composition were obviously distinct. Combining
the phenotype and genotype identiﬁcation, JDM601 should
be a novel Mycobacterium species between RGM and SGM in
the evolutionary process of mycobacteria.
Pathogenicity
Mycolic acids correlate with the pathogenicity and antibiotic
resistance of mycobacteria [14]. The similar mycolic acid
composition of JDM601 and M. nonchromogenicum, a well-
known pathogenic member of the MTEC, possibly facilitated
the pathogenicity of M. sinense.
There are reports discussing the evolution of NTM with
complete genome sequenced from non-pathogenic to patho-
genic [15,16]. JDM601 was more similar to human patho-
genic mycobacterium than to saprophytic mycobacterium
because of its relatively small genome and higher coding per-
centage (Table 3). The smaller genome of JDM601 compared
with other non-pathogenic NTMs indicates genome degener-
ation because of its parasitic lifestyle, and the higher percent-
age of nucleotide usage provides genomic proof of the
evolution toward cytoparasitic life.
Most of the small number of protein families found in
JDM601 have been associated with mycobacterial pathogenic-
ity. There were more copies of proline-glutamate/proline-
proline glutamate proteins and early secretory antigenic target
6 secretion system clusters coding genes in H37Rv than in
JDM601, which conﬁrmed mycobacterial virulence factors
involved in intracellular parasitism [17]. Seven complete and
two fragmentary mammalian cell entry (MCE) proteins were
found in JDM601; there were seven mce operons in M. absces-
sus and only four in M. smegmatis [15]. Other genes coding
virulence factors, such as YrbE and MgtC, were also found in
TABLE 2. Ten antibiotic MICs for Mycobacterium sinense
JDM601
Drug Reference MIC (mg/L) JDM601 (mg/L)
Isoniazid 0.2 >50
Rifampin 40 50
Streptomycin 4 32
Ciproﬂoxacin 1 15
Levoﬂoxacin 1 5
Amikacin 20 32
Capromycin 10 32
Euteropas 0.5 >16
Protionamide 20 64
Ethambutol 2 >0.5
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JDM601. Additionally, the cysteine desulphurase gene is a hall-
mark of organisms living in soil or water, suggesting the organ-
ism’s original environment. The mycolic acid composition and
genome composition indicated that JDM601 might be an
opportunistic pathogen with weaker virulence than M. tuber-
culosis. Animal infection experiments will be implemented to
establish stricter deﬁnition.
Antibiotic resistance genes
The hazard of NTM infection lies in the widespread and
high-level of antibiotic resistance but not in the virulence.
Some mechanisms of antibiotic resistance were shown by
the JDM601 genome sequence. Isoniazid is a pro-drug that
requires activation by the catalase-peroxidase enzyme
encoded by the katG gene [18]. The absence of katG made
JDM601 completely resistant to isoniazid.
Approximately 95% of rifampin-resistant M. tuberculosis
strains carry mutations within the rifampin resistance-deter-
mining region (RRDR), an 81-bp region carrying codons 507
through 533 of the rpoB gene [19]. The mutations of RRDR in
JDM601 were nonsense mutations. Some rifampin-resistant
NTM with no identiﬁable rpoB mutations suggested that
another mechanism of resistance might be present. Mycobacte-
rium smegmatis inactivates rifampin through ribosylation using
rifampin ADP-ribosyl transferase (arr) [20]. JDM601_1063
was an arr gene that might have been responsible for the
rifampin resistance of JDM601. Compared with non-redun-
dant protein sequences on NCBI, JDM601_1063 was similar
to M. smegmatis with a low identity rate of 51%; the highest
identity rate was 76% with the gene in a Gordonia species.
Resistance to aminoglycoside antibiotics has been shown
to result from mutations in S12 (rpsL) and the 16S rDNA
gene (rrs). Compared with H37Rv, the whole rpsL genes of
the two strains had only two amino-acid mutations: Gly12
changed into Ser and Ser124 changed into Gly. No reported
mutation codons were found in rrs at amino acids 530, 491,
915 or 1401 [21,22]. The identity rate between the two
strains was 97% with 50 single nucleotide polymorphisms.
Conclusion
According to this study, JDM601 had the highest MIC and
the most extensive antibiotic resistance proﬁle among all
clinically isolated strains we got. To facilitate NTM and even
M. tuberculosis antibiotic resistance research, we determined
the complete genome sequence of M. sinense JDM601. This
is also the ﬁrst report to describe the isolation and identiﬁ-
cation of a novel mycobacterium species collected in China
that is highly antibiotic resistant and is associated with inva-
sive human infections. In addition, it was the ﬁrst genome
sequence analysis of an MTEC strain. The complete genome
of JDM601 will form the foundation of further research on
both its pathogenicity and antibiotic resistance.
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